Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera in ESA-naive Pre-dialysis Patients With Chronic Renal Anemia
NCT00661388Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2008
- Primary completion
- Dec 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Primary endpoint: Mean Change in Hemoglobin Concentration Between Baseline and the Efficacy Evaluation Period. Started Aug 2008; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00661388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661388.